Title : At JPM, the NASH flood gates start to crack
link : At JPM, the NASH flood gates start to crack
At JPM, the NASH flood gates start to crack
J.P. Morgan Healthcare Conference in San FranciscoAt JPM, the NASH flood gates start to crack
Jacob Bell
Four companies are within striking distance of filing NASH drugs for approval, but the competitive landscape is more nuanced than simply crossing the finish line first...
While JPM didn't bring data updates for the later-stage NASH pipeline, drugmakers did give more color on their mindset heading into such a pivotal year....
John McHutchison, Gilead's head of R&D, told investors at JPM he anticipates "waves of approval," with the first being highly potent treatments for patients who have more advanced fibrosis, and then subsequent waves that work on less severe NASH and have better safety profiles.....
Read the article:
https://www.biopharmadive.com/news/nash-2019-jpm-readouts-deals-market-competition/545772/
Articles available on this blog:
Nonalcoholic Steatohepatitis (NASH)Articles available on this blog:
Non-alcoholic Fatty Liver Disease (NAFLD)
Thus Article At JPM, the NASH flood gates start to crack
That's an article At JPM, the NASH flood gates start to crack This time, hopefully can give benefits to all of you. well, see you in posting other articles.
You are now reading the article At JPM, the NASH flood gates start to crack with the link address https://theleknews.blogspot.com/2019/01/at-jpm-nash-flood-gates-start-to-crack.html
0 Response to "At JPM, the NASH flood gates start to crack"
Post a Comment